ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionNeuberger Berman Group LLC
Latest Disclosed Ownership60,300 shares
Latest Disclosed Value $ 13,536,166
Neuberger Berman Group LLC reports 23.64% increase in ownership of RMD / ResMed Inc.

On May 14, 2026 - Neuberger Berman Group LLC filed a 13F-HR form disclosing ownership of 60,300 shares of ResMed Inc. (MX:RMD) valued at $13,536,166 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 48,770 shares of ResMed Inc.. This represents a change in shares of 23.64% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F RESMED Common 761152107 60,300 11,530 23.64 13,536 15.23 0.0053
2026-02-13 2025-12-31 13F RESMED Common 761152107 48,770 -12,189 -20.00 11,747 -29.60 0.0087
2025-11-12 2025-09-30 13F RESMED Common 761152107 60,959 7,043 13.06 16,686 19.96 0.0122
2025-08-25 2025-06-30 13F/A-1 RESMED Common 761152107 53,916 22,431 71.24 13,910 97.39 0.0107
2025-08-13 2025-06-30 13F RESMED Common 761152107 53,916 22,431 13,910 0.0055
2025-05-13 2025-03-31 13F RESMED Common 761152107 31,485 4,855 18.23 7,048 15.73 0.0059
2025-02-13 2024-12-31 13F RESMED Common 761152107 26,630 7,586 39.83 6,090 30.97 0.0048
2024-11-14 2024-09-30 13F RESMED Common 761152107 19,044 11,368 148.10 4,649 216.47 0.0036
2024-11-14 2024-06-30 13F/A-1 RESMED Common 761152107 7,676 -169 -2.15 1,469 -5.41 0.0012
2024-08-13 2024-06-30 13F RESMED Common 761152107 7,676 -169 1,469 0.0012
2024-11-14 2024-03-31 13F/A-1 RESMED Common 761152107 7,845 475 6.45 1,554 22.57 0.0013
2024-05-13 2024-03-31 13F RESMED Common 761152107 7,845 475 1,554 0.0013
2024-11-14 2023-12-31 13F/A-2 RESMED Common 761152107 7,370 1,399 23.43 1,268 43.65 0.0011
2024-02-09 2023-12-31 13F RESMED Common 761152107 7,370 1,399 1,268 0.0011
2023-11-14 2023-09-30 13F RESMED Common 761152107 5,971 -6,011 -50.17 883 -66.31 0.0008
2023-08-11 2023-06-30 13F RESMED Common 761152107 11,982 -588 -4.68 2,618 -4.87 0.0023
2023-05-12 2023-03-31 13F RESMED Common 761152107 12,570 -3,543 -21.99 2,753 -17.92 0.0026
2023-02-13 2022-12-31 13F RESMED Common 761152107 16,113 -281 -1.71 3,354 -6.31 0.0033
2022-11-15 2022-09-30 13F RESMED Common 761152107 16,394 -2,526 -13.35 3,579 -9.76 0.0037
2022-08-15 2022-06-30 13F RESMED Common 761152107 18,920 -2,331 -10.97 3,966 -23.05 0.0040
2022-05-23 2022-03-31 13F/A-1 RESMED Common 761152107 21,251 2,204 11.57 5,154 15.69 0.0044
2022-05-13 2022-03-31 13F RESMED Common 761152107 21,251 2,204 4,768 0.0021
2022-02-11 2021-12-31 13F RESMED Common 761152107 19,047 4,996 35.56 4,455 31.26 0.0035
2021-11-12 2021-09-30 13F RESMED Common 761152107 14,051 2,136 17.93 3,394 23.46 0.0030
2021-08-13 2021-06-30 13F RESMED Common 761152107 11,915 -7,087 -37.30 2,749 -23.74 0.0024
2021-05-13 2021-03-31 13F RESMED Common 761152107 19,002 3,149 19.86 3,605 8.13 0.0034
2021-02-10 2020-12-31 13F RESMED Common 761152107 15,853 5,583 54.36 3,334 90.95 0.0035
2020-11-12 2020-09-30 13F RESMED Common 761152107 10,270 1,779 20.95 1,746 7.91 0.0021
2020-08-13 2020-06-30 13F RESMED Common 761152107 8,491 -493 -5.49 1,618 22.21 0.0020
2020-05-14 2020-03-31 13F RESMED Common 761152107 8,984 -181 -1.97 1,324 -6.76 0.0020
2020-02-12 2019-12-31 13F RESMED Common 761152107 9,165 1,179 14.76 1,420 31.60 0.0017
2019-11-13 2019-09-30 13F RESMED Common 761152107 7,986 1,147 16.77 1,079 29.22 0.0013
2019-08-13 2019-06-30 13F RESMED Common 761152107 6,839 1,837 36.73 835 60.58 0.0010
2019-05-13 2019-03-31 13F RESMED Common 761152107 5,002 1,717 52.27 520 39.04 0.0006
2019-02-12 2018-12-31 13F RESMED Common 761152107 3,285 0 0.00 374 -1.32 0.0005
2018-11-16 2018-09-30 13F/A-1 RESMED Common 761152107 3,285 -148 -4.31 379 6.46 0.0004
2018-11-13 2018-09-30 13F RESMED Common 761152107 3,285 -148 379
2018-08-13 2018-06-30 13F RESMED Common 761152107 3,433 797 30.24 356 36.92 0.0004
2018-05-08 2018-03-31 13F RESMED Common 761152107 2,636 -26 -0.98 260 15.56 0.0003
2018-02-14 2017-12-31 13F RESMED Common 761152107 2,662 2,662 225 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.